Evidence map›Paper›PMID 41911435›Full record

Trial reportJournal of medical Internet research2026

Digital Intervention (MiVacunaLA 2.0) to Promote COVID-19 Vaccine Acceptance Among Hispanic Children: Community-Based Randomized Controlled Trial.

Luisa R Blanco, Alexandra Klomhaus, Rebecca Dudovitz, Denise Marquez, Ray Lopez-Chang, Evelyn Aleman, Bas Weerman, Michael Moldoff, Keith Norris, Yelba Castellon-Lopez

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of medical Internet research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Luisa R BlancoSchool of Public Policy, Pepperdine University, 24255 Pacific Coast Highway, Malibu, CA, 90263, United States, 1 310-506-7466.ORCID http://orcid.org/0000-0003-3609-0645
Alexandra KlomhausDepartment of Medicine, David Geffen School of Medicine, Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, Los Angeles, CA, United States.ORCID http://orcid.org/0000-0002-7676-3595
Rebecca DudovitzDepartment of Pediatrics, David Geffen School of Medicine, Division of General Pediatrics, University of California, Los Angeles, Los Angeles, CA, United States.ORCID http://orcid.org/0000-0001-9457-0562
Denise MarquezSelf-Sufficiency Services, Office of Immigrant and Refugee Affairs, County of San Diego, Health and Human Services Agency, San Diego, CA, United States.ORCID http://orcid.org/0009-0007-6211-5590
Ray Lopez-ChangCenter for Economic and Social Research, USC Dornsife, University of Southern California, Los Angeles, CA, United States.ORCID http://orcid.org/0009-0003-5612-5582
Evelyn AlemanOur Voice: Communities for Quality Education (Nuestra Voz), Los Angeles, CA, United States.ORCID http://orcid.org/0009-0006-0174-023X
Bas WeermanCenter for Economic and Social Research, USC Dornsife, University of Southern California, Los Angeles, CA, United States.ORCID http://orcid.org/0009-0007-5926-7286
Michael MoldoffCenter for Economic and Social Research, USC Dornsife, University of Southern California, Los Angeles, CA, United States.ORCID http://orcid.org/0009-0004-3400-981X
Keith NorrisDepartment of Medicine, David Geffen School of Medicine, Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, Los Angeles, CA, United States.ORCID http://orcid.org/0000-0003-3071-0700
Yelba Castellon-LopezCancer Research Center for Health Equity, Samuel Oschin Comprehensive Cancer Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.ORCID http://orcid.org/0000-0002-4886-7792

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early in the children's COVID-19 rollout in the United States, racial and ethnic vaccination rate disparities were evident. Based on COVID-19 communication literature and qualitative interviews with Hispanic parents, we developed a mobile phone-delivered digital intervention to address factors associated with low vaccine confidence. Objective: We conducted a community-based randomized controlled trial of a digital intervention called MiVacunaLA/MyShotLA to increase COVID-19 vaccine uptake among Hispanic children. The fully automated digital intervention was designed in collaboration with community organizations and linguistically and culturally tailored to meet the informational needs of Hispanic caregivers. The intervention focused on families with unvaccinated children 5 to 11 years old but was offered to families with any unvaccinated children 17 years or younger. Methods: Participants were recruited with community organization partners and trained parent ambassadors via an open online screener. The 4-week intervention consisted of 3 SMS text messages with culturally and linguistically tailored educational information weekly. Intervention materials were delivered digitally through a closed online platform. Study team members were blinded. We used a difference-in-difference model with an intention-to-treat approach. The primary outcome was self-reported COVID-19 vaccine uptake among household children collected via online questionnaires. Secondary outcomes included COVID-19 vaccine knowledge, vaccine trust, and measures of participant engagement. We conducted a sensitivity analysis using the treatment-on-the-treated approach. Results: In total, 254 participants completed the baseline survey (128 control and 126 intervention). The average participant age was 34 (SD 6.3) years with an average of 1.7 (SD 0.8) minors in the household, and among households, 62.2% (n=158) reported having children aged 5 to 11 years old. Most participants (n=207, 81.5%) reported English as their primary language. We found a statistically significant difference of 13.3% (95% CI 0.3%-26.4%; P=.04) points in self-reported vaccine uptake between intervention and control groups among caregivers of Hispanic children aged 5 to 11 years old. We also found a statistically significant point difference of 14.3% (95% CI 0%-23.7%; P=.003) between intervention and control groups in trust of governmental approval processes for the children's COVID-19 vaccine. Most participants reported that the weekly digital videos and educational information were "very" (892/1031, 86.5%) or "extremely" (888/1019, 87.1%) useful. Conclusions: MiVacunaLA demonstrates that a culturally tailored, community-based, mobile phone-delivered vaccine educational intervention can increase COVID-19 vaccine uptake among Hispanic children and improve caregivers' trust in governmental vaccine processes. MiVacunaLA is innovative in its integration of community-informed design with a fully automated, mobile phone-centric format and builds on prior literature by prospectively evaluating a culturally tailored, SMS text messaging-linked web curriculum in a community setting. Findings provide evidence that scalable, low-cost, digital strategies can measurably improve trust and uptake in a population facing persistent vaccination gaps. Real-world implications include the portability and adaptability of this approach across diverse communities and settings to support timely, community-engaged vaccination efforts for broader applicability and scalability in public health.

Indexed as

Adherence InterventionsCOVID-19COVID-19 VaccinesHispanic or LatinoChildChild, PreschoolFemaleHumansMaleParentsText MessagingVaccinationCOVID-19 Vaccineschildren digital educationCOVID-19 vaccineshealth equityLatino/Hispanic childrenmobile-based interventions

Identifiers

PMID41911435
PMCPMC13035084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.